Article: Financial and Strategic Analysis of the Sales Outlook for Big Pharma, Mid Pharma, Japan Pharma and Biotech.

Article: Key Challenges and Issues Facing the Pharmaceutical Company ...
Business Wire;  January 20, 2008 ;     700+ words ... ... of the Sales Outlook for Big Pharma, Mid Pharma, Japan Pharma and Biotech ... Sales-Outlook-for-Big- Pharma-Mid-Pharma-Japan-Pharma-and ... Sales Outlook to 2012 for Big Pharma, Mid Pharma, Japan Pharma and Biotech ...

Article: Mid Pharma looks outside itself to drive revenue.
M2 Presswire;  August 25, 2006 ;     700+ words ... ... Schering into Big Pharma', leaving behind ... other end of the Mid Pharma scale are companies ... respectively. As a group, Mid Pharma recorded total ethical ... 10. In fact, Mid Pharma growth is expected to outstrip Big Pharma' growth during ...

Article: Does Big Pharma still exist?
Pharmaceutical Executive Europe (Online);  July 22, 2009 ;     700+ words ... ... and ABPI as clear evidence that the Big Pharma model is breaking up. In many ways ... taken for granted. The first is that Big Pharma sticks together. As recently as 2006, when my book Big Pharma was published,1 there was still a ...

Article: Mid-Pharma Companies Pulling in Profits through ...
Business Wire;  September 13, 2006 ;     700+ words ... ... c42013) has announced the addition of Mid Pharma Sector: In-licensing and Other Externalization ... to their offering. E[acute accent]Mid Pharma companies are EU/US based pharmaceutical ... 10bn. An integral component of the Mid Pharma business model is securing access to ...

Article: A Comprehensive Big Pharma M&A Analysis to 2012 - ...
M2 Presswire;  October 13, 2008 ;     700+ words ... ... Research and Markets: A Comprehensive Big Pharma M&A Analysis to 2012 - Surveying ... researchandmarkets.com/research/fa352c/big_pharma_ma_ana) has announced the addition of the "Big Pharma M&A Analysis to 2012 - Surveying ...

Article: A Comprehensive Big Pharma M&A Analysis to 2012 - ...
Business Wire;  October 13, 2008 ;     700+ words ... ... researchandmarkets.com/research/ed3063/big_pharma_ma_ana) has announced the addition of the "Big Pharma M&A Analysis to 2012 - Surveying ... to fall below their historic levels, Big Pharma must act to bolster its performance out ...

Article: BIO-EUROPE 2007 AS BIG PHARMA MODEL FALTERS, ...
BIOWORLD Today;  November 13, 2007 ;     700+ words ... ... BIO-Europe 2007. "What is it about big pharma that allows the strong to become weak ... produced no vehement rebuttals even from big pharma representatives at Monday's panel on ... have a high innovation environment at a big pharma," he said. "It's hard for me to ...